Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Parzanese

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Transplantation Proceedings|September 27, 2005
Anti-HLA antibodies in kidney transplanted patientsD Maccarone, C Cervelli, I Parzanese, et al.
The Journal of Rheumatology|February 1, 1996
Peripheral blood mononuclear cells of patients with systemic sclerosis produce increased amounts of interleukin 6, but not transforming growth factor beta 1R Giacomelli, P Cipriani, C Danese, et al.
Transplantation Proceedings|September 27, 2005
Waiting list for kidney transplantsD Maccarone, I Parzanese, L Caniglia, et al.
Clinical and Experimental Immunology|October 1, 1994
Increase of circulating gamma/delta T lymphocytes in the peripheral blood of patients affected by active inflammatory bowel diseaseR Giacomelli, I Parzanese, G Frieri, et al.
Journal of Clinical & Laboratory Immunology|January 1, 1992
Natural killer cell frequency and function in patients with monoclonal gammopathiesG Famularo, A D'Ambrosio, F Quintieri, et al.
Clinical and Experimental Immunology|April 7, 1998
Serum levels of soluble CD30 are increased in ulcerative colitis (UC) but not in Crohn's disease (CD)R Giacomelli, A Passacantando, I Parzanese, et al.
Clinical and Experimental Immunology|February 5, 1999
Circulating soluble factor-inhibiting natural killer (NK) activity of fresh peripheral blood mononuclear cells (PBMC) from inflammatory bowel disease (IBD) patientsR Giacomelli, A Passacantando, G Frieri, et al.
Transplantation Proceedings|November 18, 2022
Analysis of Risk Factors for a Low Immune Response to Messenger RNA COVID-19 Vaccine in Kidney Transplant Recipients and Differences Between Second and Third DoseA Panarese, A Canossi, R Fabiani, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Transplantation Proceedings|September 27, 2005
Anti-HLA antibodies in kidney transplanted patientsD Maccarone, C Cervelli, I Parzanese, et al.
The Journal of Rheumatology|February 1, 1996
Peripheral blood mononuclear cells of patients with systemic sclerosis produce increased amounts of interleukin 6, but not transforming growth factor beta 1R Giacomelli, P Cipriani, C Danese, et al.
Transplantation Proceedings|September 27, 2005
Waiting list for kidney transplantsD Maccarone, I Parzanese, L Caniglia, et al.
Clinical and Experimental Immunology|October 1, 1994
Increase of circulating gamma/delta T lymphocytes in the peripheral blood of patients affected by active inflammatory bowel diseaseR Giacomelli, I Parzanese, G Frieri, et al.
Journal of Clinical & Laboratory Immunology|January 1, 1992
Natural killer cell frequency and function in patients with monoclonal gammopathiesG Famularo, A D'Ambrosio, F Quintieri, et al.
Clinical and Experimental Immunology|April 7, 1998
Serum levels of soluble CD30 are increased in ulcerative colitis (UC) but not in Crohn's disease (CD)R Giacomelli, A Passacantando, I Parzanese, et al.
Clinical and Experimental Immunology|February 5, 1999
Circulating soluble factor-inhibiting natural killer (NK) activity of fresh peripheral blood mononuclear cells (PBMC) from inflammatory bowel disease (IBD) patientsR Giacomelli, A Passacantando, G Frieri, et al.
Transplantation Proceedings|November 18, 2022
Analysis of Risk Factors for a Low Immune Response to Messenger RNA COVID-19 Vaccine in Kidney Transplant Recipients and Differences Between Second and Third DoseA Panarese, A Canossi, R Fabiani, et al.
Pageof 2